Research progress on neutralizing epitopes and antibodies for the Rabies virus

[1]  Shenmin Zhang,et al.  Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models. , 2022, Travel medicine and infectious disease.

[2]  D. Scaravelli,et al.  Spillover of West Caucasian Bat Lyssavirus (WCBV) in a Domestic Cat and Westward Expansion in the Palearctic Region , 2021, Viruses.

[3]  C. Rupprecht,et al.  A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis , 2021, PloS one.

[4]  W. Markotter,et al.  Lagos Bat Virus, an Under-Reported Rabies-Related Lyssavirus , 2021, Viruses.

[5]  Shuo Su,et al.  Development of Monoclonal Antibodies for Detection of Conserved and Variable Epitopes of Large Protein of Rabies Virus , 2021, Viruses.

[6]  S. Finke,et al.  Genetic and Antigenetic Characterization of the Novel Kotalahti Bat Lyssavirus (KBLV) , 2021, Viruses.

[7]  Wei Hu,et al.  Change in the Single Amino Acid Site 83 in Rabies Virus Glycoprotein Enhances the BBB Permeability and Reduces Viral Pathogenicity , 2021, Frontiers in Cell and Developmental Biology.

[8]  M. Gourlaouen,et al.  Rabies control in Liberia: Joint efforts towards Zero by 30. , 2020, Acta tropica.

[9]  D. Corti,et al.  A combination of two human monoclonal antibodies cures symptomatic rabies , 2020, EMBO molecular medicine.

[10]  Pankaj Kalita,et al.  A Phase 3, Randomised, Open-Label, Non-inferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG). , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Maolin Zhang,et al.  Rabies Viruses in Specific Wild Fur Animals in Northern China, 2017-2019. , 2020, Transboundary and emerging diseases.

[12]  D. Marston,et al.  Rabies in the African Civet: An Incidental Host for Lyssaviruses? , 2020, Viruses.

[13]  S. Roche,et al.  Crystal structure of Mokola virus glycoprotein in its post-fusion conformation , 2020, PLoS pathogens.

[14]  A. Telenti,et al.  Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein , 2020, Nature Communications.

[15]  Yuquan Wei,et al.  Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing Antibody. , 2020, Cell host & microbe.

[16]  S. Suwarno,et al.  Antigenic site of nucleoprotein gene from Indonesian rabies virus isolates , 2019, Veterinary world.

[17]  S. Moore.  Rabies: Current Preventive Strategies. , 2019, The Veterinary clinics of North America. Small animal practice.

[18]  Zhao,et al.  Generation of Monoclonal Antibodies against Variable Epitopes of the M Protein of Rabies Virus , 2019, Viruses.

[19]  Z. Fu,et al.  Deficient Incorporation of Rabies Virus Glycoprotein into Virions Enhances Virus-Induced Immune Evasion and Viral Pathogenicity , 2019, Viruses.

[20]  Y. Gaudin,et al.  Structural and cellular biology of rhabdovirus entry. , 2019, Advances in virus research.

[21]  A. Orłowska,et al.  Bokeloh bat lyssavirus isolation in a Natterer’s bat, Poland , 2018, Zoonoses and public health.

[22]  Yongge Wu,et al.  Comparison of rabies virus protection by single chain and leucine zipper Fv fragments cocktail derived from a monoclonal antibody cocktail , 2018, Molecular immunology.

[23]  Z. Bu,et al.  Metabotropic glutamate receptor subtype 2 is a cellular receptor for rabies virus , 2018, PLoS pathogens.

[24]  A. Takada,et al.  The Role of Heparan Sulfate Proteoglycans as an Attachment Factor for Rabies Virus Entry and Infection , 2018, The Journal of infectious diseases.

[25]  E. Wright,et al.  Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses. , 2018, The Journal of general virology.

[26]  N. Gogtay,et al.  Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Finke,et al.  Comparative pathogenesis of rabies in bats and carnivores, and implications for spillover to humans. , 2018, The Lancet. Infectious diseases.

[28]  C. Rupprecht,et al.  SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies , 2017, PLoS neglected tropical diseases.

[29]  A. Virtala,et al.  Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2 , 2017, Acta Veterinaria Scandinavica.

[30]  H. Wilde,et al.  Rabies: Still a silent killer targeting the poor. , 2017, Vaccine.

[31]  E. Stokstad.  Taming rabies. , 2017, Science.

[32]  Antoine M. van Oijen,et al.  Mechanism of membrane fusion induced by vesicular stomatitis virus G protein , 2016, Proceedings of the National Academy of Sciences.

[33]  L. Martens,et al.  The Lyssavirus glycoprotein: A key to cross-immunity. , 2016, Virology.

[34]  S. Van Gucht,et al.  Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection , 2016, PLoS neglected tropical diseases.

[35]  S. Nadin-Davis,et al.  Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants. , 2016, Virus research.

[36]  De-xin Li,et al.  [Development of Recombinant Human Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis]. , 2016, Bing du xue bao = Chinese journal of virology.

[37]  R. Weiss,et al.  Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis , 2016, EMBO molecular medicine.

[38]  De-xin Li,et al.  Viral suppression function of intracellular antibody against C-terminal domain of rabies virus phosphoprotein. , 2015, Acta biochimica et biophysica Sinica.

[39]  P. Vanlandschoot,et al.  Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice , 2014, PloS one.

[40]  S. Finke,et al.  Rabies Virus Hijacks and Accelerates the p75NTR Retrograde Axonal Transport Machinery , 2014, PLoS pathogens.

[41]  S. Finke,et al.  Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus , 2014, The Journal of general virology.

[42]  N. Johnson,et al.  Current status of rabies and prospects for elimination , 2014, The Lancet.

[43]  C. Wirblich,et al.  Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment. , 2013, Vaccine.

[44]  S. Whelan,et al.  Uptake of Rabies Virus into Epithelial Cells by Clathrin-Mediated Endocytosis Depends upon Actin , 2013, Journal of Virology.

[45]  Y. Bi,et al.  Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG. , 2013, Virus research.

[46]  Shou-feng Zhang,et al.  Isolation of Irkut Virus from a Murina leucogaster Bat in China , 2013, PLoS neglected tropical diseases.

[47]  A. Easton,et al.  Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine? , 2012, Vaccine.

[48]  De-xin Li,et al.  Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein , 2012, Applied Microbiology and Biotechnology.

[49]  C. V. van Dolleweerd,et al.  Passive immunity in the prevention of rabies. , 2012, The Lancet. Infectious diseases.

[50]  Rajendra Lingala,et al.  Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein , 2011, Biotechnology research international.

[51]  R. Weiss,et al.  Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules , 2011, PloS one.

[52]  M. Lafon.  Rabies virus receptors , 2005, Journal of NeuroVirology.

[53]  H. Liu,et al.  Fine mapping and interaction analysis of a linear rabies virus neutralizing epitope. , 2010, Microbes and infection.

[54]  Z. Fu,et al.  Characterization of conformation-specific monoclonal antibodies against rabies virus nucleoprotein , 2010, Archives of Virology.

[55]  Thomas Müller,et al.  Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans , 2009, PLoS neglected tropical diseases.

[56]  S. Kostense,et al.  First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. , 2008, Vaccine.

[57]  J. Blanton,et al.  Rabies surveillance in the United States during 2007. , 2008, Journal of the American Veterinary Medical Association.

[58]  W. Marasco,et al.  The growth and potential of human antiviral monoclonal antibody therapeutics , 2007, Nature Biotechnology.

[59]  M. Koltzenburg,et al.  The Rabies Virus Glycoprotein Receptor p75NTR Is Not Essential for Rabies Virus Infection , 2007, Journal of Virology.

[60]  C. Hanlon,et al.  Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. , 2006, The Journal of infectious diseases.

[61]  Patrick England,et al.  Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor. , 2005, The Journal of general virology.

[62]  N. Johnson,et al.  Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. , 2005, Vaccine.

[63]  J. Blanton,et al.  Efficacy of rabies biologics against new lyssaviruses from Eurasia. , 2005, Virus research.

[64]  Jaap Goudsmit,et al.  Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants , 2005, Journal of Virology.

[65]  C. Rupprecht,et al.  Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis , 2005, Journal of Virology.

[66]  N. Johnson,et al.  Identification of a conserved linear epitope at the N terminus of the rabies virus glycoprotein. , 2004, The Journal of general virology.

[67]  C. Hanlon,et al.  Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. , 2003, Virus research.

[68]  C. Hanlon,et al.  Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. , 2003, The Journal of infectious diseases.

[69]  K. Morimoto,et al.  Structural relationship between nucleocapsid-binding activity of the rabies virus phosphoprotein (P) and exposure of epitope 402-13 located at the C terminus. , 2002, The Journal of general virology.

[70]  C. Langevin,et al.  Mutations Conferring Resistance to Neutralization by a Soluble Form of the Neurotrophin Receptor (p75NTR) Map outside of the Known Antigenic Sites of the Rabies Virus Glycoprotein , 2002, Journal of Virology.

[71]  Y. Gaudin,et al.  Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type. , 2002, The Journal of general virology.

[72]  G. Gosztonyi,et al.  Interactions of viral proteins with neurotransmitter receptors may protect or destroy neurons. , 2001, Current topics in microbiology and immunology.

[73]  S. Nadin-Davis,et al.  A Panel of Monoclonal Antibodies Targeting the Rabies Virus Phosphoprotein Identifies a Highly Variable Epitope of Value for Sensitive Strain Discrimination , 2000, Journal of Clinical Microbiology.

[74]  H. Goto,et al.  Mapping of epitopes and structural analysis of antigenic sites in the nucleoprotein of rabies virus. , 2000, The Journal of general virology.

[75]  B. Kieffer,et al.  Low‐affinity nerve‐growth factor receptor (P75NTR) can serve as a receptor for rabies virus , 1998, The EMBO journal.

[76]  M. Schachner,et al.  The Neural Cell Adhesion Molecule Is a Receptor for Rabies Virus , 1998, Journal of Virology.

[77]  C. Tuffereau,et al.  An Avirulent Mutant of Rabies Virus Is Unable To Infect Motoneurons In Vivo and In Vitro , 1998, Journal of Virology.

[78]  H. Goto,et al.  A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. , 1997, Virus research.

[79]  K. Conzelmann,et al.  Budding of Rabies Virus Particles in the Absence of the Spike Glycoprotein , 1996, Cell.

[80]  L. Role,et al.  Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. , 1995, Annual review of physiology.

[81]  A. Osterhaus,et al.  Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. , 1993, The Journal of general virology.

[82]  Y. Gaudin,et al.  Antigenicity of rabies virus glycoprotein , 1991, Journal of virology.

[83]  L. Astic,et al.  Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation , 1991, Virology.

[84]  A. Osterhaus,et al.  Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine , 1990, Journal of virology.

[85]  C. Tuffereau,et al.  Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. , 1989, Virology.

[86]  A. Osterhaus,et al.  Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. , 1989, The Journal of general virology.

[87]  A. Flamand,et al.  Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence , 1988, Journal of virology.

[88]  P. Rollin,et al.  Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein , 1985, Journal of virology.

[89]  D. Speicher,et al.  Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. , 1984, Science.

[90]  T. Wiktor,et al.  Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. , 1983, The Journal of general virology.

[91]  A. Anilionis,et al.  Structure of the glycoprotein gene in rabies virus , 1981, Nature.